Zhejiang Shouxiangu Pharm Co Asset Resilience Ratio

Latest as of March 2026: 12.69%

Zhejiang Shouxiangu Pharm Co asset resilience ratio. Zhejiang Shouxiangu Pharm Co (603896) has an Asset Resilience Ratio of 12.69% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Zhejiang Shouxiangu Pharm Co defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥408.33 Million
≈ $59.75 Million USD Cash + Short-term Investments

Total Assets

CN¥3.22 Billion
≈ $470.95 Million USD All company assets

Resilience Assessment

Moderate
Financial Resilience Level

Asset Resilience Ratio of Zhejiang Shouxiangu Pharm Co (2015–2025)

Asset resilience ratio of Zhejiang Shouxiangu Pharm Co from 2015 to 2025. This chart shows how Zhejiang Shouxiangu Pharm Co's Asset Resilience Ratio has changed over time. Read debt load of Zhejiang Shouxiangu Pharm Co for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Shouxiangu Pharm Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Zhejiang Shouxiangu Pharm Co (603896) total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥408.33 Million 12.69%
Total Liquid Assets CN¥408.33 Million 12.69%

Asset Resilience Insights

  • Moderate Liquidity: Zhejiang Shouxiangu Pharm Co has 12.69% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company has significant short-term investments, indicating active treasury management.

Zhejiang Shouxiangu Pharm Co Industry Peers by Asset Resilience Ratio

Compare Zhejiang Shouxiangu Pharm Co's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
argenx NV ADR
NASDAQ:ARGX
Biotechnology 15.95%
Tubize-Fin
BR:TUB
Biotechnology 2.50%
Ascendis Pharma AS
NASDAQ:ASND
Biotechnology 0.00%
Summit Therapeutics PLC
NASDAQ:SMMT
Biotechnology 36.07%
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Biotechnology 62.31%
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Biotechnology 0.00%
Verona Pharma PLC ADR
NASDAQ:VRNA
Biotechnology 0.00%
3SBio Inc
F:83B
Biotechnology 10.64%

Zhejiang Shouxiangu Pharm Co Asset Resilience Ratio by Year (2015–2025)

Zhejiang Shouxiangu Pharm Co asset resilience ratio by year from 2015 to 2025. The table below shows the annual Asset Resilience Ratio data for Zhejiang Shouxiangu Pharm Co.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 10.85% CN¥356.16 Million
≈ $52.12 Million
CN¥3.28 Billion
≈ $480.19 Million
-0.15pp
2024-12-31 11.01% CN¥344.69 Million
≈ $50.44 Million
CN¥3.13 Billion
≈ $458.19 Million
+9.96pp
2022-12-31 1.05% CN¥30.00 Million
≈ $4.39 Million
CN¥2.86 Billion
≈ $417.95 Million
-5.57pp
2021-12-31 6.62% CN¥130.00 Million
≈ $19.02 Million
CN¥1.96 Billion
≈ $287.17 Million
+3.68pp
2020-12-31 2.94% CN¥50.00 Million
≈ $7.32 Million
CN¥1.70 Billion
≈ $248.70 Million
-11.86pp
2019-12-31 14.80% CN¥198.50 Million
≈ $29.05 Million
CN¥1.34 Billion
≈ $196.20 Million
+12.18pp
2018-12-31 2.62% CN¥31.22 Million
≈ $4.57 Million
CN¥1.19 Billion
≈ $174.36 Million
-20.91pp
2017-12-31 23.53% CN¥218.00 Million
≈ $31.90 Million
CN¥926.34 Million
≈ $135.55 Million
+21.79pp
2016-12-31 1.74% CN¥10.67 Million
≈ $1.56 Million
CN¥612.10 Million
≈ $89.57 Million
-0.82pp
2015-12-31 2.56% CN¥15.50 Million
≈ $2.27 Million
CN¥605.91 Million
≈ $88.66 Million
--
pp = percentage points

About Zhejiang Shouxiangu Pharm Co

SHG:603896 China Biotechnology
Market Cap
$397.72 Million
CN¥2.72 Billion CNY
Market Cap Rank
#13060 Global
#3853 in China
Share Price
CN¥13.71
Change (1 day)
-1.15%
52-Week Range
CN¥12.95 - CN¥22.30
All Time High
CN¥56.07
About

Zhejiang Shouxiangu Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the breeding, cultivation, processing, and sale of Chinese medicinal herbs in China and internationally. The company offers ganoderma lucidum spore powder, dendrobium officinale, and saffron products, as well as health and ordinary food, agricultural and sideline products, personal and skincare, and tradition… Read more